NO992531L - Fremgangsmåter ved fremstilling av rekombinant protein - Google Patents
Fremgangsmåter ved fremstilling av rekombinant proteinInfo
- Publication number
- NO992531L NO992531L NO992531A NO992531A NO992531L NO 992531 L NO992531 L NO 992531L NO 992531 A NO992531 A NO 992531A NO 992531 A NO992531 A NO 992531A NO 992531 L NO992531 L NO 992531L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- producing recombinant
- recombinant protein
- proteins
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/757,177 US6071718A (en) | 1996-11-27 | 1996-11-27 | Methods of producing a recombinant protein |
PCT/US1997/022095 WO1998023762A2 (fr) | 1996-11-27 | 1997-11-24 | Procedes de production d'une proteine de recombinaison |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992531D0 NO992531D0 (no) | 1999-05-26 |
NO992531L true NO992531L (no) | 1999-07-27 |
Family
ID=25046717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992531A NO992531L (no) | 1996-11-27 | 1999-05-26 | Fremgangsmåter ved fremstilling av rekombinant protein |
Country Status (6)
Country | Link |
---|---|
US (1) | US6071718A (fr) |
EP (1) | EP0941347A2 (fr) |
JP (1) | JP2001506489A (fr) |
CA (1) | CA2272988A1 (fr) |
NO (1) | NO992531L (fr) |
WO (1) | WO1998023762A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287866B1 (en) * | 1996-11-27 | 2001-09-11 | Abbott Laboratories | β-casein expressing constructs |
KR100369839B1 (ko) * | 1997-02-28 | 2003-06-12 | 주식회사 엘지생명과학 | 바실러스리케니포미스균주에서유래한아미노펩티다제,그의제조방법및이를이용한천연형단백질의제조방법 |
US7109015B2 (en) * | 2004-03-29 | 2006-09-19 | Academia Sinica | Removal of N-terminal methionine from proteins by engineered methionine aminopeptidase |
WO2021188379A2 (fr) | 2020-03-16 | 2021-09-23 | Fina Biosolutions, Llc | Production de protéine recombinante soluble |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL60184A (en) * | 1979-05-31 | 1984-05-31 | Schering Ag | Process for the specific cleavage of protein sequences from proteins |
US5013662A (en) * | 1985-09-20 | 1991-05-07 | Cetus Corporation | Bacterial methionine n-terminal peptidase |
DE3822045A1 (de) * | 1988-06-30 | 1990-01-11 | Hoechst Ag | Verfahren zur herstellung von proteinen |
US5506209A (en) * | 1994-05-26 | 1996-04-09 | Abbott Laboratories | Product for inhibition of infection of mammalian cells by respiratory syncytial virus |
US5538952A (en) * | 1994-05-26 | 1996-07-23 | Abbott Laboratories | Inhibition of infection of mammalian cells by respiratory syncytial virus |
JPH11500918A (ja) * | 1995-02-27 | 1999-01-26 | アボツト・ラボラトリーズ | 細菌系内で修飾組換えタンパク質を発現させるための方法 |
-
1996
- 1996-11-27 US US08/757,177 patent/US6071718A/en not_active Expired - Lifetime
-
1997
- 1997-11-24 JP JP52490498A patent/JP2001506489A/ja active Pending
- 1997-11-24 WO PCT/US1997/022095 patent/WO1998023762A2/fr not_active Application Discontinuation
- 1997-11-24 EP EP97950791A patent/EP0941347A2/fr not_active Withdrawn
- 1997-11-24 CA CA002272988A patent/CA2272988A1/fr not_active Abandoned
-
1999
- 1999-05-26 NO NO992531A patent/NO992531L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6071718A (en) | 2000-06-06 |
CA2272988A1 (fr) | 1998-06-04 |
JP2001506489A (ja) | 2001-05-22 |
NO992531D0 (no) | 1999-05-26 |
WO1998023762A2 (fr) | 1998-06-04 |
WO1998023762A3 (fr) | 1998-10-29 |
EP0941347A2 (fr) | 1999-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076113A1 (en) | Specific binding agents of human angiopoietin-2 | |
AU4162400A (en) | Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii | |
MX9801159A (es) | Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob. | |
MXPA02004666A (es) | Gelatinas recombinantes. | |
WO1996034107A3 (fr) | Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations | |
BG102071A (en) | Minor molecule inhibitors of rotamase enzymic activity | |
DK1149905T3 (da) | Fremgangsmåder og præparat til polypeptidteknologi | |
IL124831A0 (en) | Ob protein derivatives having prolonged half-life | |
BG103091A (en) | Shortened soluble receptors of type i & ii of the tumour necrotizing factor | |
NO20006191L (no) | Vaksine | |
SE8902532D0 (sv) | Bestaemning av plasmaproteiner | |
DE122007000030I1 (de) | Für menschliches Papillomavirus stamm 18 kodierende DNS | |
EP0716591A4 (fr) | PROCEDES ET COMPOSITIONS DESTINES A FIXER DES PROTEINES TAU ET MAP2c | |
IL187595A0 (en) | Antitumor antibodies, proteins, and uses thereof | |
NO992531L (no) | Fremgangsmåter ved fremstilling av rekombinant protein | |
DE69836333D1 (de) | Neisseria lactoferrin-bindendes protein | |
EP1443055A3 (fr) | Interleukines-21 et 22 | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
ES2122912A1 (es) | Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales. | |
AU7079300A (en) | Compositions and methods for the treatment of immune related diseases | |
ES2191785T3 (es) | Proteina de accion antitumoral. | |
TW200635950A (en) | Specific binding agents of human angiopoietin-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |